DOCSLIB.ORG

Due to Medial Calcaneal Nerve Treatment of Painful Heels with 4% Alcohol Injection

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Due to Medial Calcaneal Nerve Treatment of Painful Heels with 4% Alcohol Injection “Dock” DOCKERY, DPM [email protected] Treatment of Painful Heels Due to Medial Calcaneal Nerve Treatment of Painful Heels with 4% Alcohol Injection Dock Dockery, DPM, FACFAS Fellow, American College of Foot & Ankle Surgeons; Fellow, American Society of Foot & Ankle Dermatology; Fellow, American College of Foot & Ankle Pediatrics; Fellow, American College of Foot & Ankle Orthopedics and Medicine; Board Certified, American Board of Foot & Ankle Surgery; Board Certified, American Board Podiatric Medicine; Author of: - Color Atlas & Text of Forefoot Surgery (Mosby 1992); - Cutaneous Disorders of the Lower Extremity (WB Saunders 1997); - Color Atlas of Foot & Ankle Dermatology (Lippincott 1999); - Lower Extremity Soft Tissue & Cutaneous Plastic Surgery (Elsevier 2012) Chairman and Director of Scientific Affairs, International Foot & Ankle Foundation; Everett, Washington [email protected] Examination of Plantar Fascia – Medial Calcaneal Condyle Direct Pressure to fascia Direct Pressure to fascia Insertion with Thumb Insertion with Finger Diagnosis of Heel Pain Inferior Calcaneal Bursitis Diagnosis of Heel Pain Retrocalcaneal Bursitis/AICT Diagnosis of Heel Pain Inferior Calcaneal Periostitis/Fracture Pulling-Distraction causes increased discomfort Diagnosis of Heel Pain Piezogenic Papules Insertion of PF Dockery GL, Diana JL: Painful piezogenic papules. JAPA,1978;680(10):703-705. Diagnosis of Heel Pain Piezogenic Papules P.T. Nerve, Tendon Area of MCN Insertion of PF Diagnosis of Heel Pain TARSAL TUNNEL SYNDROME A Cause of Heel Pain Heel pain accompanied by neuropathic features such as tingling, burning, or numbness may indicate tarsal tunnel syndrome, a compression neuropathy caused by entrapment of the posterior tibial nerve branches within the tunnel. Aldridge T. Diagnosis of Heel Pain in Adults. Am Fam Physician, 2004, 70(2):332-338. Diagnosis of Heel Pain Insertional Plantar Fasciitis Insertional Plantar Fasciitis vs Medial Calcaneal Neuropathy Medial Calcaneal Nerve Pain Medial Calcaneal Nerve Pain Medial Calcaneal Nerve Pain Medial Calcaneal Nerve Pain 1st Branch of Lateral Plantar Nerve Pain (Baxter’s Neuritis) • Baxter DE, Thigpen CM: Heel Pain – operative results. Foot Ankle 5:16-25, 1984. • Baxter DE, Pfeffer GB. Treatment of chronic heel pain by surgical release of the first branch of the lateral plantar nerve. Clin Orthop Relat Res. 1992; (279):229-36. 1st Branch of Lateral Plantar Nerve Pain (Baxter’s Neuritis) Abductor Digiti Minimi • Baxter DE, Thigpen CM: Heel Pain – operative results. Foot Ankle 5:16-25, 1984. • Baxter DE, Pfeffer GB. Treatment of chronic heel pain by surgical release of the first branch of the lateral plantar nerve. Clin Orthop Relat Res. 1992; (279):229-236. • Baxter DE. “Release of the Nerve to the Abductor Digiti Minimi” in Master Techniques in Orthopaedic Surgery of The Foot and Ankle, p 359, Lippincott Williams and Wilkins, Phila, PA, 2002. Treatment of Heel Pain Medial Calcaneal Nerve Pain My “Preferred Treatment” Dilute solution (4%) of ethyl alcohol injected into medial calcaneal nerve region of heel. Done once per week (or every 10 days) until symptoms resolve (up to seven injections) 4% Alcohol Injection Treatment of Painful Heels 4 % ALCOHOL SOLUTION: 48 cc of Local Anesthetic* *(0.5% bupivacaine w/ epinephrine) + 2 cc of Dehydrated Alcohol = 50 cc of 4% Sclerosing 4% Alcohol Injection Treatment of Painful Heels 48 cc of Local Anesthetic* *(0.5% bupivacaine w/ epinephrine) + 2 cc of Dehydrated Alcohol 4% Alcohol Injection Treatment of Painful Heels **IMPORTANT** • Make a NEW label for the bottle to prevent accidental injection of the 4% Alcohol Sclerosing Solution! 4% Alcohol Injection Treatment of Painful Heels Add a NEW Label, 4% and Date Mixture Made 4% Alcohol Injection Treatment of Painful Heels 1. “This alcohol solution has a very high affinity for nerve tissue and it produces neuritis and Wallerian nerve degeneration (chemical neurolysis)” 2. May cause a fine thin fibrous scar when injected at the deep dermal layers. Dockery GL: Evaluation and Treatment of Metatarsalgia and Keratotic Lesions, in Myerson M (ed): Foot and Ankle Disorders, W.B. Saunders. Phila., ch. 12, p.359-377, 2000. 4% Alcohol Injection Treatment of Painful Heels INJECTION METHOD: • 0.5 cc (1/2 ml) of 4% Alcohol Solution • 27 gauge, 5/8 inch needle • Inject proximal to nerve pain • Repeat Weekly (5 - 10 days) – injections Minimum: 3 Maximum: 7 ICD-9 Diagnostic Codes: Prior to 2016 • 355.8 neuritis, peripheral • 355.9 nerve entrapment • 997.61 amputation neuroma • 956.4 nerve injury, skin/sensory • 956.9 nerve injury, unspecified • 729.5 pain, lower extremity ICD-10 Diagnostic Codes: 355.8--neuritis, peripheral 977.61--amputation neuroma G57.6 Lesion of plantar nerve Complication (s) (from) (of) amputation stump (surgical) (late) T87.9 G57.60 …… unspecified lower limb neuroma T87.30 G57.61 …… right lower limb 956.4--nerve injury, skin/sensory G57.62 …… left lower limb S94.3 Injury of cutaneous sensory nerve at ankle and G57.8 Other specified mononeuropathies of lower foot level limb S94.30 Injury of cutaneous sensory nerve at ankle G57.80 Other specified mononeuropathies of and foot level, unspecified leg unspecified lower limb S94.30XA …… initial encounter S94.30XD …… subsequent encounter G57.81 Other specified mononeuropathies of S94.30XS …… sequelae right lower limb S94.31 Injury of cutaneous sensory nerve at ankle G57.82 Other specified mononeuropathies of and foot level, right leg left lower limb S94.31XA …… initial encounter S94.31XD …… subsequent encounter 355.9--nerve entrapment S94.31XS …… sequelae Neuropathy, neuropathic S94.32 Injury of cutaneous sensory nerve at ankle entrapment G58.9 and foot level, left leg S94.32XA …… initial encounter S94.32XD …… subsequent encounter S94.32XS …… sequelae And…. ICD-10 Diagnostic Codes: 956.9--nerve injury, unspecified S94.8 Injury of other nerves at ankle and foot 729.5--pain in lower extremity level M79.66 Pain in lower leg S94.8X Injury of other nerves at ankle M79.661 Pain in right lower leg and foot level M79.662 Pain in left lower leg M79.669 Pain in unspecified lower leg S94.8X1 Injury of other nerves at M79.67 Pain in foot and toes ankle and foot level, right leg M79.671 Pain in right foot S94.8X1A …… initial encounter M79.672 Pain in left foot S94.8X1D …… subsequent M79.673 Pain in unspecified foot encounter M79.674 Pain in right toe(s) S94.8X1S …… sequelae M79.675 Pain in left toe(s) S94.8X2 Injury of other nerves at ankle and M79.676 Pain in unspecified toe(s) foot level, left leg S94.8X2A …… initial encounter S94.8X2D …… subsequent encounter S94.8X2S …… sequelae S94.8X9 Injury of other nerves at ankle and foot level, unspecified leg S94.8X9A …… initial encounter S94.8X9D …… subsequent encounter S94.8X9S …… sequelae MEDIAL CALCANEAL NERVE ENTRAPMENT MEDIAL CALCANEAL NERVE ENTRAPMENT Not All Heel Pain is Plantar Fasciitis or Insertional Fasciosis Dockery GL: Dilute Alcohol Injections for Nerve Conditions and Keratotic Lesions of the Foot. Podiatry Management. p.117-126, January 2004. 2018 CPT Codes • 64455: Injection(s), anesthetic agent and/or steroid, plantar common digital nerve (e.g. Morton’s Neuroma) • 64632: Destruction by Neurolytic Agent; plantar common digital nerve or peripheral nerve (i.e. alcohol) • 64632 has a 10 day global and can be used instead of 64640. • Do not report 64632 and 64455 together References • Dockery GL: Treatment of Intermetatarsal Neuromas with 4% Alcohol Sclerosing Injections. JFAS, 38 (6): 403-408, 1999. • Masala S, Fanucci E, Ronconi P, et al: Treatment of intermetatarsal neuromas with 30% alcohol injections under US guide. Radiol Med (Torino) 2001; 102:370-373. • Fanucci E, Masala S, Fabiano S, et al: Treatment of intermetatarsal Morton’s neuroma with 10% alcohol injection under US guide: a 10- month follow-up. Eur Radiol. 2003 Mar;14(3):514-8. • Hyer CF, Mehl LR, Block AJ, Vancourt RB: Treatment of Recalcitrant Intermetatarsal Neuromas with 4% Sclerosing Alcohol. JFAS, 44(4):287-291, 2005.[73% improved] • Mozena J, Clifford J: Efficacy of Chemical Neurolysis for Treatment of Interdigital Nerve Compression of the Foot. JAPMA 97(3):203-206, 2007. [74% w/ 5 or more inj = 74% improved] • Hughes RJ, Ali K, Jones H, Kendall S, Connell DA: Treatment of Morton’s Neuroma with Alcohol Injections Under Sonographic Guidance: Follow-up of 101 Cases. Am J. Roentgenology, 188:1535- 1539, 2007.[84% pain free/94% improved] Additional References • Alshami AM, Souvlis T and Coppieters MW: A review of plantar heel pain of neural origin: Differential diagnosis and management, Manual Therapy, (13)2:103-111, 2008. • Arenson DJ, Cosentino GL, Suran SM: The inferior calcaneal nerve. JAPA 70: 552, 1980. • Baxter DE, Thigpen CM: Heel Pain-operative results. Foot Ankle 5:16, 1984. • Baxter DE, Pfeffer GB: Treatment of chronic heel pain by surgical release of the first branch of the lateral plantar nerve. Clin Orthop 279: 229, 1992. • Baxter DE. “Release of the Nerve to the Abductor Digiti Minimi” in Master Techniques in Orthopaedic Surgery of The Foot and Ankle, ed by HB Kitaoka, p 359, Lippincott Williams and Wilkins, Philadelphia, 2002. • Dellon AL. Deciding when heel pain is of neural origin. J Foot Ankle Surg 40(5):341-5, 2001. • Dellon AL, Kim J, Spaulding CM. Variations in the origin of the medial calcaneal nerve. J Am Podiatr Med Assoc 92(2):97-101, 2002. • Dockery GL: Dilute Alcohol Injections for Nerve Conditions and Keratotic Lesions of the Foot. Podiatry Management. p.117-126, January 2004. • Lareau CR, et al. Plantar and medial heel pain: diagnosis and management. JAAOS. 22(6):372-80, 2014. • Panchbhavi VK. Plantar Heel Pain. Medscape Emedicine, Mar 2014. http://emedicine.medscape.com/article/1233178-overview • Rondhuis JJ, Huson A: The first branch of the lateral plantar nerve and heel pain. Acta Morphol Neerl Scand 24: 269-279, 1986. • Sammarco GJ, Helfrey RB: Surgical treatment of recalcitrant plantar fasciitis.
Load more

Recommended publications
  • Piriformis Syndrome Is Overdiagnosed 11 Robert A
    American Association of Neuromuscular & Electrodiagnostic Medicine AANEM CROSSFIRE: CONTROVERSIES IN NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE Loren M. Fishman, MD, B.Phil Robert A.Werner, MD, MS Scott J. Primack, DO Willam S. Pease, MD Ernest W. Johnson, MD Lawrence R. Robinson, MD 2005 AANEM COURSE F AANEM 52ND Annual Scientific Meeting Monterey, California CROSSFIRE: Controversies in Neuromuscular and Electrodiagnostic Medicine Loren M. Fishman, MD, B.Phil Robert A.Werner, MD, MS Scott J. Primack, DO Willam S. Pease, MD Ernest W. Johnson, MD Lawrence R. Robinson, MD 2005 COURSE F AANEM 52nd Annual Scientific Meeting Monterey, California AANEM Copyright © September 2005 American Association of Neuromuscular & Electrodiagnostic Medicine 421 First Avenue SW, Suite 300 East Rochester, MN 55902 PRINTED BY JOHNSON PRINTING COMPANY, INC. ii CROSSFIRE: Controversies in Neuromuscular and Electrodiagnostic Medicine Faculty Loren M. Fishman, MD, B.Phil Scott J. Primack, DO Assistant Clinical Professor Co-director Department of Physical Medicine and Rehabilitation Colorado Rehabilitation and Occupational Medicine Columbia College of Physicians and Surgeons Denver, Colorado New York City, New York Dr. Primack completed his residency at the Rehabilitation Institute of Dr. Fishman is a specialist in low back pain and sciatica, electrodiagnosis, Chicago in 1992. He then spent 6 months with Dr. Larry Mack at the functional assessment, and cognitive rehabilitation. Over the last 20 years, University of Washington. Dr. Mack, in conjunction with the Shoulder he has lectured frequently and contributed over 55 publications. His most and Elbow Service at the University of Washington, performed some of the recent work, Relief is in the Stretch: End Back Pain Through Yoga, and the original research utilizing musculoskeletal ultrasound in order to diagnose earlier book, Back Talk, both written with Carol Ardman, were published shoulder pathology.
    [Show full text]
  • Sensory Conduction in Medial and Lateral Plantar Nerves
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.51.2.188 on 1 February 1988. Downloaded from Journal ofNeurology, Neurosurgery, and Psychiatry 1988;51:188-191 Sensory conduction in medial and lateral plantar nerves S N PONSFORD From the Department of Clinical Neurophysiology, Walsgrave Hospital, Coventry, UK SUMMARY A simple and reliable method of recording medial and lateral plantar nerve sensory action potentials is described. Potentials are recorded with surface electrodes at the ankle using surface electrodes stimulating orthodromically at the sole. The normal values obtained are higher in amplitude than those obtained by the method described by Guiloff and Sherratt and are detectable in older subjects aged over 80 years. The procedure is valuable in the diagnosis of early peripheral neuropathy, mononeuritig multiplex; tarsal tunnel syndrome and in differentiation between pre and post ganglionic L5 SI lesions. The value of medial plantar sensory action potential EL53051 applied to the sole just lateral to the first meta-guest. Protected by copyright. (SAP) recording in the diagnosis of peripheral neuro- tarsal, the anode level with metatarsophalangeal joint, the pathy and investigation of root or individual nerve cathode thus overlying the first common digital nerve sub- lesions involving the leg or foot was clearly estab- serving contiguous surfaces ofthe great and second toes. For the lateral plantar, the stimulator was placed between the lished by Guiloff and Sherratt.1 However, their fourth and fifth metatarsals, the anode-again level with the method of stimulating at the big toe and recording at metatarsophalangeal joint, overlying the fourth common the ankle gives potentials of relatively small ampli- digital nerve supplying contiguous surfaces of the fourth and tude (mean amplitude 2-3 pv, range 0-8- 1).
    [Show full text]
  • Dr Peter Heppner Consultant Neurosurgeon Auckland City Hospital Starship Childrens Hospital Ascot Hospital
    Dr Peter Heppner Consultant Neurosurgeon Auckland City Hospital Starship Childrens Hospital Ascot Hospital 14:00 - 14:55 WS #55: Case Studies on Managing Cervical Radiculopathy 15:05 - 16:00 WS #67: Case Studies on Managing Cervical Radiculopathy (Repeated) Case Studies on Managing Cervical Radiculopathy: Peter Heppner Neurosurgeon Auckland City Hospital Starship Childrens Hospital Ascot Private Hospital www.neurosurgeon.org.nz DISCLOSURES I have no actual or potential conflict of interest in relation to this presentation WHAT ARE THE TAKE HOME POINTS? Evidence relating to cervical radiculopathy management is poor Natural history is generally very good In the absence of red flags, initial management with analgesia and physiotherapy appropriate NRIs can be a useful therapeutic and diagnostic tool Surgery ideally considered between 3-6 months from onset Either anterior or posterior surgical approaches can be selected depending on specifics of the case CASE 1 58 yr old lady 2 weeks radiating left arm pain (?after pilates) Taking paracetamol and NSAID Mild parasthesia in thumb Neuro exam normal Neck Disability Index 28% (mild) Clinically: Mild C6 radiculopathy of short duration CERVICAL RADICULOPATHY Radiating arm pain in a nerve distribution due to mechanical compression/chemical irritation of the nerve root Referred pain to inter-scapular and lateral neck common Weakness usually mild Pain or parasthesia non-dermatomal in almost half of patients Reduced reflex best predictor of imaging findings>motor weakness>sensory
    [Show full text]
  • Carpal Tunnel Syndrome: a Review of the Recent Literature I
    The Open Orthopaedics Journal, 2012, 6, (Suppl 1: M8) 69-76 69 Open Access Carpal Tunnel Syndrome: A Review of the Recent Literature I. Ibrahim*,1, W.S. Khan1, N. Goddard2 and P. Smitham1 1University College London Institute of Orthopaedics and Musculoskeletal Sciences, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, HA7 4LP, UK 2 Department of Trauma & Orthopaedics, Royal Free Hospital, Pond Street, London, NW3 2QG, UK Abstract: Carpal Tunnel Syndrome (CTS) remains a puzzling and disabling condition present in 3.8% of the general population. CTS is the most well-known and frequent form of median nerve entrapment, and accounts for 90% of all entrapment neuropathies. This review aims to provide an overview of this common condition, with an emphasis on the pathophysiology involved in CTS. The clinical presentation and risk factors associated with CTS are discussed in this paper. Also, the various methods of diagnosis are explored; including nerve conduction studies, ultrasound, and magnetic resonance imaging. Keywords: Carpal tunnel syndrome, median nerve, entrapment neuropathy, pathophysiology, diagnosis. WHAT IS CARPAL TUNNEL SYNDROME? EPIDEMIOLOGY First described by Paget in 1854 [1], Carpal Tunnel CTS is the most frequent entrapment neuropathy [2], Syndrome (CTS) remains a puzzling and disabling condition believed to be present in 3.8% of the general population [14]. 1 commonly presented to Rheumatologists and Orthopaedic in every 5 subjects who complains of symptoms such as pain, Hand clinicians. It is a compressive neuropathy, which is numbness and a tingling sensation in the hands is expected to defined as a mononeuropathy or radiculopathy caused by have CTS based on clinical examination and electrophysio- mechanical distortion produced by a compressive force [2].
    [Show full text]
  • Lower Extremity Focal Neuropathies
    LOWER EXTREMITY FOCAL NEUROPATHIES Lower Extremity Focal Neuropathies Arturo A. Leis, MD S.H. Subramony, MD Vettaikorumakankav Vedanarayanan, MD, MBBS Mark A. Ross, MD AANEM 59th Annual Meeting Orlando, Florida Copyright © September 2012 American Association of Neuromuscular & Electrodiagnostic Medicine 2621 Superior Drive NW Rochester, MN 55901 Printed by Johnson Printing Company, Inc. 1 Please be aware that some of the medical devices or pharmaceuticals discussed in this handout may not be cleared by the FDA or cleared by the FDA for the specific use described by the authors and are “off-label” (i.e., a use not described on the product’s label). “Off-label” devices or pharmaceuticals may be used if, in the judgment of the treating physician, such use is medically indicated to treat a patient’s condition. Information regarding the FDA clearance status of a particular device or pharmaceutical may be obtained by reading the product’s package labeling, by contacting a sales representative or legal counsel of the manufacturer of the device or pharmaceutical, or by contacting the FDA at 1-800-638-2041. 2 LOWER EXTREMITY FOCAL NEUROPATHIES Lower Extremity Focal Neuropathies Table of Contents Course Committees & Course Objectives 4 Faculty 5 Basic and Special Nerve Conduction Studies of the Lower Limbs 7 Arturo A. Leis, MD Common Peroneal Neuropathy and Foot Drop 19 S.H. Subramony, MD Mononeuropathies Affecting Tibial Nerve and its Branches 23 Vettaikorumakankav Vedanarayanan, MD, MBBS Femoral, Obturator, and Lateral Femoral Cutaneous Neuropathies 27 Mark A. Ross, MD CME Questions 33 No one involved in the planning of this CME activity had any relevant financial relationships to disclose.
    [Show full text]
  • A Historical Approach to Hereditary Spastic Paraplegia
    r e v u e n e u r o l o g i q u e 1 7 6 ( 2 0 2 0 ) 2 2 5 – 2 3 4 Available online at ScienceDirect www.sciencedirect.com History of Neurology A historical approach to hereditary spastic paraplegia O. Walusinski Private practice, 20, rue de Chartres, 28160 Brou, France i n f o a r t i c l e a b s t r a c t Article history: Hereditary spastic paraplegia (HSP) is a group of rare neurological disorders, characterised Received 12 August 2019 by their extreme heterogeneity in both their clinical manifestations and genetic origins. Received in revised form Although Charles-Prosper Ollivier d’Angers (1796–1845) sketched out a suggestive descrip- 25 November 2019 tion in 1827, it was Heinrich Erb (1840–1921) who described the clinical picture, in 1875, for Accepted 26 November 2019 ‘‘spastic spinal paralysis’’. Jean-Martin Charcot (1825–1893) began teaching the disorder as a Available online 3 January 2020 clinical entity this same year. Adolf von Stru¨mpell (1853–1925) recognised its hereditary nature in 1880 and Maurice Lorrain (1867–1956) gained posthumous fame for adding his Keywords: name to that of Stru¨mpell and forming the eponym after his 1898 thesis, the first review Hereditary spastic paraplegia covering twenty-nine affected families. He benefited from the knowledge accumulated over Weakness a dozen years on this pathology by his teacher, Fulgence Raymond (1844–1910). Here I Motor neuron disease present a history across two centuries, leading to the clinical, anatomopathological, and Neurodegeneration genetic description of hereditary spastic paraplegia which today enables a better unders- Stru¨mpell-Lorrain syndrome tanding of the causative cellular dysfunctions and makes it possible to envisage effective History of neurology treatment.
    [Show full text]
  • 101-Carpal Tunnel Syndrome
    Focus on CME at the University of Calgary Carpal Tunnel Syndrome The non-idiopathic causes of carpal tunnel syndrome (CTS) involve intrinsic and extrinsic conditions responsible for nerve compression. To establish a work-related association, there should be a history of excessive or unusual hand use of a nature known to be associated with CTS prior to the onset of symptoms. By Ron Gorsché, MD, MMedSc (Occupational Health), CCFP arpal tunnel syndrome (CTS) is responsible about CTS and it is among the most controversial C for the most time lost in the workplace, yet of disorders. This article focuses on how recent lit- there is little consensus regarding work as a erature has contributed to the theories of patho- causative factor of the syndrome. Little is known physiology and pathogenesis of CTS, and pro- vides clinicians with a more scientific approach Dr. Gorsché is clinical associate pro- to causative factors and treatment. fessor, departments of family medi- cine and community health sciences, faculty of medicine, University of Historical Perspectives Calgary, and director, Work-Related In 1860, Paget reported the first cases of median Upper Limb Disorders Research nerve compression of the wrist — one case attrib- Unit, Calgary, Alberta. He is also uted the disorder to a tight band wrapped around active staff, High River General the wrist and the other cited complications asso- Hospital, High River, Alberta. ciated with a fractured distal radius.1 In 1941, The Canadian Journal of CME / October 2001 101 Carpal Tunnel Syndrome Woltman first postulated the possibility of nerve toms of CTS. This approach works well for the compression within the carpal tunnel as a cause of clinician attempting to explain the syndrome to a “median neuritis,” after reporting 12 cases associ- patient, but requires further classification for epi- ated with acromegaly.2 demiological study.
    [Show full text]
  • POLYNEURITIS by G
    413 Postgrad Med J: first published as 10.1136/pgmj.35.405.413 on 1 July 1959. Downloaded from POLYNEURITIS By G. S. GRAVESON, M.A., M.D., F.R.C.P. Consultant Neurologist, Wessex Regional Hospital Board (From the Southampton General Hospital) Diseases affecting the lower motor and sensory acid and vitamin B.I2. Thiamine is a constituent neurones, diffusely and usually symmetrically, are of the coenzyme cocarboxylase, which is necessary grouped together under the title polyneuritis. The for the oxidation of pyruvic acid formed in the term is imprecise, for many of these diseases affect metabolism of glucose by nerve cells. It is also structures other than peripheral nerves, e.g. concerned in the synthesis of acetylocholine in spinal nerve cells, roots and muscles, and few of nerve fibres. Its deficiency, therefore, results in them are really inflammatory disorders. To over- neuronal degeneration and the accumulation of an come this inaccuracy, such terms as polyradiculo- excess of pyruvate in the blood. This may be neuropathy and neuromyopathy have been coined present in the fasting state or it may be brought but the older word still serves, with better out by a loading dose of glucose. Joiner, McArdle euphony perhaps, provided it is used merely in and Thompson (1950) describe the use of such aProtected by copyright. the sense of a condition in which lesions of peri- 'pyruvate metabolism test ' in the investigation of pheral nerves occur. Its retention may be ad- cases of polyneuritis. Lack of thiamine may be a visable, too, until such time as the pathogenesis of contributory factor in the polyneuritis of chronic the various types of the disease have been more alcoholism and in those cases which complicate fully elucidated.
    [Show full text]
  • Foot and Ankle Disorders Capturing Motion with Ultrasound
    VISIT THE AANEM MARKETPLACE AT WWW.AANEM.ORG FOR NEW PRODUCTS AMERICAN ASSOCIATION OF NEUROMUSCULAR & ELECTRODIAGNOSTIC MEDICINE Foot and Ankle Disorders Capturing Moti on With Ultrasound: Blood, Muscle, Needle, and Nerve Photo by Michael D. Stubblefi eld, MD Foot and Ankle Nerve Disorders Tracy A. Park, MD David R. Del Toro, MD Atul T. Patel, MD, MHSA Jeffrey A. Mann, MD AANEM 58th Annual Meeting San Francisco, California Copyright © September 2011 American Association of Neuromuscular & Electrodiagnostic Medicine 2621 Superior Drive NW Rochester, MN 55901 Printed by Johnson’s Printing Company, Inc. 1 Please be aware that some of the medical devices or pharmaceuticals discussed in this handout may not be cleared by the FDA or cleared by the FDA for the specific use described by the authors and are “off-label” (i.e., a use not described on the product’s label). “Off-label” devices or pharmaceuticals may be used if, in the judgment of the treating physician, such use is medically indicated to treat a patient’s condition. Information regarding the FDA clearance status of a particular device or pharmaceutical may be obtained by reading the product’s package labeling, by contacting a sales representative or legal counsel of the manufacturer of the device or pharmaceutical, or by contacting the FDA at 1-800-638-2041. 2 Foot and Ankle Nerve Disorders Table of Contents Course Objectives & Course Committee 4 Faculty 5 Tarsal Tunnel Syndromes 7 Tracy A. Park, MD First Branch Lateral Plantar Neuropathy: “Baxter’s Neuropathy” 17 David R. Del Toro, MD Foot Pain Related to Peroneal (Fibular) Nerve Entrapments (Deep and Superficial) and Digital Neuromas 25 Atul T.
    [Show full text]
  • Tibial Nerve Block: Supramalleolar Or Retromalleolar Approach? a Randomized Trial in 110 Participants
    International Journal of Environmental Research and Public Health Article Tibial Nerve Block: Supramalleolar or Retromalleolar Approach? A Randomized Trial in 110 Participants María Benimeli-Fenollar 1,* , José M. Montiel-Company 2 , José M. Almerich-Silla 2 , Rosa Cibrián 3 and Cecili Macián-Romero 1 1 Department of Nursing, University of Valencia, c/Jaume Roig s/n, 46010 Valencia, Spain; [email protected] 2 Department of Stomatology, University of Valencia, c/Gascó Oliag, 1, 46010 Valencia, Spain; [email protected] (J.M.M.-C.); [email protected] (J.M.A.-S.) 3 Department of Physiology, University of Valencia, c/Blasco Ibánez, 15, 46010 Valencia, Spain; [email protected] * Correspondence: [email protected] Received: 26 April 2020; Accepted: 23 May 2020; Published: 29 May 2020 Abstract: Of the five nerves that innervate the foot, the one in which anesthetic blocking presents the greatest difficulty is the tibial nerve. The aim of this clinical trial was to establish a protocol for two tibial nerve block anesthetic techniques to later compare the anesthetic efficiency of retromalleolar blocking and supramalleolar blocking in order to ascertain whether the supramalleolar approach achieved a higher effective blocking rate. A total of 110 tibial nerve blocks were performed. Location of the injection site was based on a prior ultrasound assessment of the tibial nerve. The block administered was 3 mL of 2% mepivacaine. The two anesthetic techniques under study provided very similar clinical results. The tibial nerve success rate was 81.8% for the retromalleolar technique and 78.2% for the supramalleolar technique.
    [Show full text]
  • Neuroanatomy for Nerve Conduction Studies
    Neuroanatomy for Nerve Conduction Studies Kimberley Butler, R.NCS.T, CNIM, R. EP T. Jerry Morris, BS, MS, R.NCS.T. Kevin R. Scott, MD, MA Zach Simmons, MD AANEM 57th Annual Meeting Québec City, Québec, Canada Copyright © October 2010 American Association of Neuromuscular & Electrodiagnostic Medicine 2621 Superior Drive NW Rochester, MN 55901 Printed by Johnson Printing Company, Inc. AANEM Course Neuroanatomy for Nerve Conduction Studies iii Neuroanatomy for Nerve Conduction Studies Contents CME Information iv Faculty v The Spinal Accessory Nerve and the Less Commonly Studied Nerves of the Limbs 1 Zachary Simmons, MD Ulnar and Radial Nerves 13 Kevin R. Scott, MD The Tibial and the Common Peroneal Nerves 21 Kimberley B. Butler, R.NCS.T., R. EP T., CNIM Median Nerves and Nerves of the Face 27 Jerry Morris, MS, R.NCS.T. iv Course Description This course is designed to provide an introduction to anatomy of the major nerves used for nerve conduction studies, with emphasis on the surface land- marks used for the performance of such studies. Location and pathophysiology of common lesions of these nerves are reviewed, and electrodiagnostic methods for localization are discussed. This course is designed to be useful for technologists, but also useful and informative for physicians who perform their own nerve conduction studies, or who supervise technologists in the performance of such studies and who perform needle EMG examinations.. Intended Audience This course is intended for Neurologists, Physiatrists, and others who practice neuromuscular, musculoskeletal, and electrodiagnostic medicine with the intent to improve the quality of medical care to patients with muscle and nerve disorders.
    [Show full text]
  • SARS-Cov-2 Infection and Guillain-Barré Syndrome
    pathogens Review SARS-CoV-2 Infection and Guillain-Barré Syndrome Huda Makhluf 1,* and Henry Madany 2 1 Department of Mathematics and Natural Sciences, National University, La Jolla, CA 92037, USA 2 Public Health, University of California, Irvine, CA 92697, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-858-642-8488 Abstract: Severe acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) is a beta-coronavirus that emerged as a global threat and caused a pandemic following its first outbreak in Wuhan, China, in late 2019. SARS-CoV-2 causes COVID-19, a disease ranging from relatively mild to severe illness. Older people and those with many serious underlying medical conditions such as diabetes, heart or lung conditions are at higher risk for developing severe complications from COVID-19 illness. SARS-CoV-2 infections of adults can lead to neurological complications ranging from headaches, loss of taste and smell, to Guillain–Barré syndrome, an autoimmune disease characterized by neurological deficits. Herein we attempt to describe the neurological manifestations of SARS-CoV2 infection with a special focus on Guillain-Barré syndrome. Keywords: SARS-CoV-2; COVID-19; Guillain-Barré Syndrome 1. Introduction Citation: Makhluf, H.; Madany, H. SARS-CoV-2 Infection and SARS-CoV-2 is an enveloped, positive-stranded RNA virus belonging to the Coron- Guillain-Barré Syndrome. Pathogens aviridae family and Betacoronavirus genus. SARS-CoV-2 and the related SARS-CoV-1 and 2021, 10, 936. https://doi.org/ MERS-CoV share several characteristics including severe disease outcomes. SARS-CoV-2 10.3390/pathogens10080936 has a ~30 Kb genome encoding 29 proteins, with four structural proteins (envelope, mem- brane, nucleocapsid, and spike), 16 nonstructural proteins, and nine accessory proteins.
    [Show full text]